Alzheimer, A. Über eine eigenartige Erkrankung der Hirnrinde. Allg. Z. Psychiatr. 64, 146–148 (1907).
Fischer, O. Miliare Nekrosen mit drusigen Wucherungen der Neurofibrillen, eine regelmässige Veränderung der Hirnrinde bei seniler Demenz. Monatsschr. Psychiatr. Neurol. 22, 361–372 (1907).
Lewy, F. H. in Handbuch der Neurologie (ed. Lewandowsky, M.) 920–933 (Springer Verlag, 1912).
Divry, P. & Florkin, M. Sur les propriétés optiques de l’amyloïde. C. R. Soc. Biol. 97, 1808–1810 (1927).
Ladewig, P. Double-refringence of the amyloid–Congo-red-complex in histological sections. Nature 156, 81–82 (1945).
Google Scholar
Cohen, A. S. & Calkins, E. Electron microscopic observations on a fibrous component in amyloid of diverse origins. Nature 183, 1202–1203 (1959).
Google Scholar
Glenner, G. G. & Wong, C. W. Alzheimer’s disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem. Biophys. Res. Commun. 120, 885–890 (1984).
Google Scholar
Masters, C. L. et al. Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc. Natl Acad. Sci. USA 82, 4245–4249 (1985).
Google Scholar
Brion, J., Passareiro, H., Nunez, J. & Flament-Durand, J. Mise en évidence immunologique de la protéine tau au niveau des lésions de dégénérescence neurofibrillaire de la maladie d’Alzheimer. Arch. Biol. 95, 229–235 (1985).
Goedert, M., Wischik, C. M., Crowther, R. A., Walker, J. E. & Klug, A. Cloning and sequencing of the cDNA encoding a core protein of the paired helical filament of Alzheimer disease: identification as the microtubule-associated protein tau. Proc. Natl Acad. Sci. USA 85, 4051–4055 (1988).
Google Scholar
Spillantini, M. G. et al. α-Synuclein in Lewy bodies. Nature 388, 839–840 (1997).
Google Scholar
Neumann, M. et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 314, 130–133 (2006).
Google Scholar
Arai, T. et al. TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem. Biophys. Res. Commun. 351, 602–611 (2006).
Google Scholar
Goate, A. et al. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer’s disease. Nature 349, 704–706 (1991).
Google Scholar
Poorkaj, P. et al. Tau is a candidate gene for chromosome 17 frontotemporal dementia. Ann. Neurol. 43, 815–825 (1998).
Google Scholar
Hutton, M. et al. Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17. Nature 393, 702–705 (1998).
Google Scholar
Spillantini, M. G. et al. Mutation in the tau gene in familial multiple system tauopathy with presenile dementia. Proc. Natl Acad. Sci. USA 95, 7737–7741 (1998).
Google Scholar
Polymeropoulos, M. H. et al. Mutation in the α-synuclein gene identified in families with Parkinson’s disease. Science 276, 2045–2047 (1997).
Google Scholar
Kabashi, E. et al. TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis. Nat. Genet. 40, 572–574 (2008).
Google Scholar
Sreedharan, J. et al. TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science 319, 1668–1672 (2008).
Google Scholar
Eanes, E. D. & Glenner, G. G. X-ray diffraction studies on amyloid filaments. J. Histochem. Cytochem. 16, 673–677 (1968).
Google Scholar
Sunde, M. et al. Common core structure of amyloid fibrils by synchrotron X-ray diffraction. J. Mol. Biol. 273, 729–739 (1997).
Google Scholar
Kidd, M. Paired helical filaments in electron microscopy of Alzheimer’s disease. Nature 197, 192–193 (1963).
Google Scholar
Crowther, R. A. Straight and paired helical filaments in Alzheimer disease have a common structural unit. Proc. Natl Acad. Sci. USA 88, 2288–2292 (1991).
Google Scholar
Nelson, R. et al. Structure of the cross-β spine of amyloid-like fibrils. Nature 435, 773–778 (2005).
Google Scholar
Rodriguez, J. A. et al. Structure of the toxic core of α-synuclein from invisible crystals. Nature 525, 486–490 (2015).
Google Scholar
Lu, J.-X. et al. Molecular structure of β-amyloid fibrils in Alzheimer’s disease brain tissue. Cell 154, 1257–1268 (2013).
Google Scholar
Petkova, A. T. et al. A structural model for Alzheimer’s β-amyloid fibrils based on experimental constraints from solid state NMR. Proc. Natl Acad. Sci. USA 99, 16742–16747 (2002).
Google Scholar
Tuttle, M. D. et al. Solid-state NMR structure of a pathogenic fibril of full-length human α-synuclein. Nat. Struct. Mol. Biol. 23, 409–415 (2016).
Google Scholar
Sachse, C., Fändrich, M. & Grigorieff, N. Paired β-sheet structure of an Aβ(1–40) amyloid fibril revealed by electron microscopy. Proc. Natl Acad. Sci. USA 105, 7462–7466 (2008).
Google Scholar
Zhang, R. et al. Interprotofilament interactions between Alzheimer’s Aβ1–42 peptides in amyloid fibrils revealed by cryoEM. Proc. Natl Acad. Sci. USA 106, 4653–4658 (2009).
Google Scholar
Kühlbrandt, W. The resolution revolution. Science 343, 1443–1444 (2014).
Google Scholar
He, S. & Scheres, S. H. W. Helical reconstruction in RELION. J. Struct. Biol. 198, 163–176 (2017). This paper reports the development of new image-processing algorithms that enabled cryo-EM structure determination of amyloid filaments to sufficient resolution for de novo atomic modelling.
Google Scholar
Fitzpatrick, A. W. P. et al. Cryo-EM structures of tau filaments from Alzheimer’s disease. Nature 547, 185–190 (2017). The is the first report of cryo-EM structures of amyloid filaments purified from human brain—tau filaments from Alzheimer’s disease.
Google Scholar
Weingarten, M. D., Lockwood, A. H., Hwo, S. Y. & Kirschner, M. W. A protein factor essential for microtubule assembly. Proc. Natl Acad. Sci. USA 72, 1858–1862 (1975).
Google Scholar
Peng, C., Trojanowski, J. Q. & Lee, V. M.-Y. Protein transmission in neurodegenerative disease. Nat. Rev. Neurol. 16, 199–212 (2020).
Google Scholar
Wischik, C. M. et al. Structural characterization of the core of the paired helical filament of Alzheimer disease. Proc. Natl Acad. Sci. USA 85, 4884–4888 (1988).
Google Scholar
Falcon, B. et al. Tau filaments from multiple cases of sporadic and inherited Alzheimer’s disease adopt a common fold. Acta Neuropathol. 136, 699–708 (2018).
Google Scholar
Falcon, B. et al. Structures of filaments from Pick’s disease reveal a novel tau protein fold. Nature 561, 137–140 (2018).
Google Scholar
Falcon, B. et al. Novel tau filament fold in chronic traumatic encephalopathy encloses hydrophobic molecules. Nature 568, 420–423 (2019).
Google Scholar
Zhang, W. et al. Novel tau filament fold in corticobasal degeneration. Nature 580, 283–287 (2020).
Google Scholar
Arakhamia, T. et al. Posttranslational modifications mediate the structural diversity of tauopathy strains. Cell 180, 633–644.e12 (2020).
Google Scholar
Shi, Y. et al. Structure-based classification of tauopathies. Nature 598, 359–363 (2021). This article classifies tauopathies on the basis of the atomic structures of tau filaments.
Google Scholar
Hallinan, G. I. et al. Structure of tau filaments in prion protein amyloidoses. Acta Neuropathol. 142, 227–241 (2021).
Google Scholar
Qi, C. et al. Tau filaments from amyotrophic lateral sclerosis/parkinsonism-dementia complex (ALS/PDC) adopt the CTE fold. Preprint at bioRxiv (2023).
Qi, C. et al. Identical tau filaments in subacute sclerosing panencephalitis and chronic traumatic encephalopathy. Acta Neuropathol. Commun. 11, 74 (2023).
Google Scholar
Wesseling, H. et al. Tau PTM profiles identify patient heterogeneity and stages of Alzheimer’s disease. Cell 183, 1699–1713.e13 (2020).
Google Scholar
Maroteaux, L., Campanelli, J. T. & Scheller, R. H. Synuclein: a neuron-specific protein localized to the nucleus and presynaptic nerve terminal. J. Neurosci. 8, 2804–2815 (1988).
Google Scholar
Davidson, W. S., Jonas, A., Clayton, D. F. & George, J. M. Stabilization of α-synuclein secondary structure upon binding to synthetic membranes. J. Biol. Chem. 273, 9443–9449 (1998).
Google Scholar
Schweighauser, M. et al. Structures of α-synuclein filaments from multiple system atrophy. Nature 585, 464–469 (2020). This study describes the first structures of α-synuclein filaments from human brains.
Google Scholar
Yang, Y. et al. Structures of α-synuclein filaments from human brains with Lewy pathology. Nature 610, 791–795 (2022).
Google Scholar
Yang, Y. et al. New SNCA mutation and structures of α-synuclein filaments from juvenile-onset synucleinopathy. Acta Neuropathol. 145, 561–572 (2023).
Google Scholar
Tziortzouda, P., Van Den Bosch, L. & Hirth, F. Triad of TDP-43 control in neurodegeneration: autoregulation, localization and aggregation. Nat. Rev. Neurosci. 22, 197–208 (2021).
Google Scholar
Mackenzie, I. R. A. et al. A harmonized classification system for FTLD–TDP pathology. Acta Neuropathol. 122, 111–113 (2011).
Google Scholar
Arseni, D. et al. Structure of pathological TDP-43 filaments from ALS with FTLD. Nature 601, 139–143 (2022). This study describes the first structures of TDP-43 filaments from human brains.
Google Scholar
Arseni, D. et al. TDP-43 forms amyloid filaments with a distinct fold in type A FTLD-TDP. Nature 620, 898–903 (2023).
Google Scholar
Tsuji, H. et al. Molecular analysis and biochemical classification of TDP-43 proteinopathy. Brain 135, 3380–3391 (2012).
Google Scholar
Haass, C. et al. Amyloid β-peptide is produced by cultured cells during normal metabolism. Nature 359, 322–325 (1992).
Google Scholar
Shoji, M. et al. Production of the Alzheimer amyloid β protein by normal proteolytic processing. Science 258, 126–129 (1992).
Google Scholar
Kang, J. et al. The precursor of Alzheimer’s disease amyloid A4 protein resembles a cell-surface receptor. Nature 325, 733–736 (1987).
Google Scholar
Tcw, J. & Goate, A. M. Genetics of β-amyloid precursor protein in Alzheimer’s disease. Cold Spring Harb. Perspect. Med. 7, a024539 (2017).
Google Scholar
Nilsberth, C. et al. The ‘Arctic’ APP mutation (E693G) causes Alzheimer’s disease by enhanced Aβ protofibril formation. Nat. Neurosci. 4, 887–893 (2001).
Google Scholar
Kollmer, M. et al. Cryo-EM structure and polymorphism of Aβ amyloid fibrils purified from Alzheimer’s brain tissue. Nat. Commun. 10, 4760 (2019). This study reports the first structures of amyloid-β filaments from human brain blood vessels.
Google Scholar
Yang, Y. et al. Cryo-EM structures of amyloid-β 42 filaments from human brains. Science 375, 167–172 (2022). This study reports the first structures of amyloid-β filaments from human brain parenchyma.
Google Scholar
Yang, Y. et al. Cryo-EM structures of amyloid-β filaments with the Arctic mutation (E22G) from human and mouse brains. Acta Neuropathol. 145, 325–333 (2023).
Google Scholar
Schöll, M. et al. Low PiB PET retention in presence of pathologic CSF biomarkers in Arctic APP mutation carriers. Neurology 79, 229–236 (2012).
Google Scholar
Schweighauser, M. et al. Age-dependent formation of TMEM106B amyloid filaments in human brains. Nature 605, 310–314 (2022).
Google Scholar
Jiang, Y. X. et al. Amyloid fibrils in FTLD-TDP are composed of TMEM106B and not TDP-43. Nature 605, 304–309 (2022).
Google Scholar
Chang, A. et al. Homotypic fibrillization of TMEM106B across diverse neurodegenerative diseases. Cell 185, 1346–1355.e15 (2022). References 67–69 report the discovery of previously unknown TMEM106B amyloid filaments using cryo-EM.
Google Scholar
Perneel, J. et al. Accumulation of TMEM106B C-terminal fragments in neurodegenerative disease and aging. Acta Neuropathol. 145, 285–302 (2023).
Google Scholar
Vicente, C. T. et al. C-terminal TMEM106B fragments in human brain correlate with disease-associated TMEM106B haplotypes. Brain (2023).
Van Deerlin, V. M. et al. Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions. Nat. Genet. 42, 234–239 (2010).
Google Scholar
Klunk, W. E. et al. Imaging brain amyloid in Alzheimer’s disease with Pittsburgh compound-B. Ann. Neurol. 55, 306–319 (2004).
Google Scholar
Xia, C.-F. et al. [18F]T807, a novel tau positron emission tomography imaging agent for Alzheimer’s disease. Alzheimers Dement. 9, 666–676 (2013).
Google Scholar
van Dyck, C. H. et al. Lecanemab in early Alzheimer’s disease. N. Engl. J. Med. 388, 9–21 (2023). This report describes a trial of the first mechanism-based therapy for Alzheimer’s disease with a measurable improvement in cognitive decline.
Google Scholar
Zhou, Y., Li, J., Nordberg, A. & Ågren, H. Dissecting the binding profile of PET tracers to corticobasal degeneration tau fibrils. ACS Chem. Neurosci. 12, 3487–3496 (2021).
Google Scholar
Künze, G. et al. Molecular simulations reveal distinct energetic and kinetic binding properties of [18F]PI-2620 on tau filaments from 3R/4R and 4R tauopathies. ACS Chem. Neurosci. 13, 2222–2234 (2022).
Google Scholar
Shi, Y. et al. Cryo-EM structures of tau filaments from Alzheimer’s disease with PET ligand APN-1607. Acta Neuropathol. 141, 697–708 (2021).
Google Scholar
Merz, G. E. et al. Stacked binding of a small molecule PET tracer to Alzheimer’s tau paired helical filaments. Preprint at bioRxiv (2022).
Shi, Y., Ghetti, B., Goedert, M. & Scheres, S. H. W. Cryo-EM structures of chronic traumatic encephalopathy tau filaments with PET ligand flortaucipir. J. Mol. Biol. 435, 168025 (2023).
Google Scholar
Pagnon de la Vega, M. et al. The Uppsala APP deletion causes early onset autosomal dominant Alzheimer’s disease by altering APP processing and increasing amyloid β fibril formation. Sci. Transl. Med. 13, eabc6184 (2021).
Google Scholar
Gremer, L. et al. Fibril structure of amyloid-β(1–42) by cryo-electron microscopy. Science 358, 116–119 (2017).
Google Scholar
Liu, D. et al. O-Glycosylation induces amyloid-β to form new fibril polymorphs vulnerable for degradation. J. Am. Chem. Soc. 143, 20216–20223 (2021).
Google Scholar
Zhang, W. et al. Heparin-induced tau filaments are polymorphic and differ from those in Alzheimer’s and Pick’s diseases. eLife 8, e43584 (2019).
Google Scholar
Abskharon, R. et al. Cryo-EM structure of RNA-induced tau fibrils reveals a small C-terminal core that may nucleate fibril formation. Proc. Natl Acad. Sci. USA 119, e2119952119 (2022).
Google Scholar
Frieg, B. et al. The 3D structure of lipidic fibrils of α-synuclein. Nat. Commun. 13, 6810 (2022).
Google Scholar
Li, B. et al. Cryo-EM of full-length α-synuclein reveals fibril polymorphs with a common structural kernel. Nat. Commun. 9, 3609 (2018).
Google Scholar
Li, Y. et al. Amyloid fibril structure of α-synuclein determined by cryo-electron microscopy. Cell Res. 28, 897–903 (2018).
Google Scholar
Guerrero-Ferreira, R. et al. Cryo-EM structure of α-synuclein fibrils. eLife 7, e36402 (2018).
Google Scholar
Ni, X., McGlinchey, R. P., Jiang, J. & Lee, J. C. Structural insights into α-synuclein fibril polymorphism: effects of Parkinson’s disease-related C-terminal truncations. J. Mol. Biol. 431, 3913–3919 (2019).
Google Scholar
Guerrero-Ferreira, R. et al. Two new polymorphic structures of human full-length α-synuclein fibrils solved by cryo-electron microscopy. eLife 8, e48907 (2019).
Google Scholar
Boyer, D. R. et al. Structures of fibrils formed by α-synuclein hereditary disease mutant H50Q reveal new polymorphs. Nat. Struct. Mol. Biol. 26, 1044–1052 (2019).
Google Scholar
Zhao, K. et al. Parkinson’s disease-related phosphorylation at Tyr39 rearranges α-synuclein amyloid fibril structure revealed by cryo-EM. Proc. Natl Acad. Sci. USA 117, 20305–20315 (2020).
Google Scholar
Zhao, K. et al. Parkinson’s disease associated mutation E46K of α-synuclein triggers the formation of a distinct fibril structure. Nat. Commun. 11, 2643 (2020).
Google Scholar
Sun, Y. et al. Cryo-EM structure of full-length α-synuclein amyloid fibril with Parkinson’s disease familial A53T mutation. Cell Res. 30, 360–362 (2020).
Google Scholar
Boyer, D. R. et al. The α-synuclein hereditary mutation E46K unlocks a more stable, pathogenic fibril structure. Proc. Natl Acad. Sci. USA 117, 3592–3602 (2020).
Google Scholar
Long, H. et al. Wild-type α-synuclein inherits the structure and exacerbated neuropathology of E46K mutant fibril strain by cross-seeding. Proc. Natl Acad. Sci. USA 118, e2012435118 (2021).
Google Scholar
Sun, Y. et al. The hereditary mutation G51D unlocks a distinct fibril strain transmissible to wild-type α-synuclein. Nat. Commun. 12, 6252 (2021).
Google Scholar
Cao, Q., Boyer, D. R., Sawaya, M. R., Ge, P. & Eisenberg, D. S. Cryo-EM structures of four polymorphic TDP-43 amyloid cores. Nat. Struct. Mol. Biol. 26, 619–627 (2019).
Google Scholar
Li, Q., Babinchak, W. M. & Surewicz, W. K. Cryo-EM structure of amyloid fibrils formed by the entire low complexity domain of TDP-43. Nat. Commun. 12, 1620 (2021).
Google Scholar
Kumar, S. T. et al. Seeding the aggregation of TDP-43 requires post-fibrillization proteolytic cleavage. Nat. Neurosci. 26, 983–996 (2023).
Google Scholar
Stern A. M, et al.Abundant Aβ fibrils in ultracentrifugal supernatants of aqueous extracts from Alzheimer’s disease brains. Neuron 111, 2012–2020.e4 (2023).
Google Scholar
Riek, R. & Eisenberg, D. S. The activities of amyloids from a structural perspective. Nature 539, 227–235 (2016).
Google Scholar
Lövestam, S. et al. Assembly of recombinant tau into filaments identical to those of Alzheimer’s disease and chronic traumatic encephalopathy. eLife 11, e76494 (2022). This article describes an in vitro assembly reaction with recombinant protein that replicates the structures of filaments extracted from human brains.
Google Scholar
Wischik, C. M. et al. Isolation of a fragment of tau derived from the core of the paired helical filament of Alzheimer disease. Proc. Natl Acad. Sci. USA 85, 4506–4510 (1988).
Google Scholar
Al-Hilaly, Y. K. et al. Tau (297–391) forms filaments that structurally mimic the core of paired helical filaments in Alzheimer’s disease brain. FEBS Lett. 594, 944–950 (2020).
Google Scholar
Goedert, M., Spillantini, M. G., Cairns, N. J. & Crowther, R. A. Tau proteins of Alzheimer paired helical filaments: abnormal phosphorylation of all six brain isoforms. Neuron 8, 159–168 (1992).
Google Scholar
Lövestam, S. & Scheres, S. H. W. High-throughput cryo-EM structure determination of amyloids. Faraday Discuss. 240, 243–260 (2022).
Google Scholar
Braak, H. & Braak, E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 82, 239–259 (1991).
Google Scholar
Braak, H. et al. Staging of brain pathology related to sporadic Parkinson’s disease. Neurobiol. Aging 24, 197–211 (2003).
Google Scholar
Brettschneider, J. et al. Stages of pTDP-43 pathology in amyotrophic lateral sclerosis. Ann. Neurol. 74, 20–38 (2013).
Google Scholar
Irwin, D. J. et al. Deep clinical and neuropathological phenotyping of Pick disease. Ann. Neurol. 79, 272–287 (2016).
Google Scholar
Duyckaerts, C., Uchihara, T., Seilhean, D., He, Y. & Hauw, J. J. Dissociation of Alzheimer type pathology in a disconnected piece of cortex. Acta Neuropathol. 93, 501–507 (1997).
Google Scholar
Frost, B. & Diamond, M. I. Prion-like mechanisms in neurodegenerative diseases. Nat. Rev. Neurosci. 11, 155–159 (2010).
Google Scholar
Jucker, M. & Walker, L. C. Self-propagation of pathogenic protein aggregates in neurodegenerative diseases. Nature 501, 45–51 (2013).
Google Scholar
Prusiner, S. B. Prions. Proc. Natl Acad. Sci. USA 95, 13363–13383 (1998).
Google Scholar
Holec, S. A. M. & Woerman, A. L. Evidence of distinct α-synuclein strains underlying disease heterogeneity. Acta Neuropathol. 142, 73–86 (2021).
Google Scholar
Jarrett, J. T. & Lansbury, P. T. Seeding ‘one-dimensional crystallization’ of amyloid: a pathogenic mechanism in Alzheimer’s disease and scrapie? Cell 73, 1055–1058 (1993).
Google Scholar
Sanders, D. W. et al. Distinct tau prion strains propagate in cells and mice and define different tauopathies. Neuron 82, 1271–1288 (2014).
Google Scholar
Meyer-Luehmann, M. et al. Exogenous induction of cerebral β-amyloidogenesis is governed by agent and host. Science 313, 1781–1784 (2006).
Google Scholar
Clavaguera, F. et al. Transmission and spreading of tauopathy in transgenic mouse brain. Nat. Cell Biol. 11, 909–913 (2009).
Google Scholar
Mougenot, A.-L. et al. Prion-like acceleration of a synucleinopathy in a transgenic mouse model. Neurobiol. Aging 33, 2225–2228 (2012).
Google Scholar
Luk, K. C. et al. Intracerebral inoculation of pathological α-synuclein initiates a rapidly progressive neurodegenerative α-synucleinopathy in mice. J. Exp. Med. 209, 975–986 (2012).
Google Scholar
Porta, S. et al. Patient-derived frontotemporal lobar degeneration brain extracts induce formation and spreading of TDP-43 pathology in vivo. Nat. Commun. 9, 4220 (2018).
Google Scholar
Burger, D., Fenyi, A., Bousset, L., Stahlberg, H. & Melki, R. Cryo-EM structure of α-synuclein fibrils amplified by PMCA from PD and MSA patient brains. Preprint at bioRxiv (2021).
Fan, Y. et al. Conformational change of α-synuclein fibrils in cerebrospinal fluid from different clinical phases of Parkinson’s disease. Structure 31, 78–87.e5 (2023).
Google Scholar
Ghosh, U., Thurber, K. R., Yau, W.-M. & Tycko, R. Molecular structure of a prevalent amyloid-β fibril polymorph from Alzheimer’s disease brain tissue. Proc. Natl Acad. Sci. USA 118, e2023089118 (2021).
Google Scholar
Xiao, Y. et al. Aβ(1–42) fibril structure illuminates self-recognition and replication of amyloid in Alzheimer’s disease. Nat. Struct. Mol. Biol. 22, 499–505 (2015).
Google Scholar
Qiang, W., Yau, W.-M., Lu, J.-X., Collinge, J. & Tycko, R. Structural variation in amyloid-β fibrils from Alzheimer’s disease clinical subtypes. Nature 541, 217–221 (2017).
Google Scholar
Lövestam, S. et al. Seeded assembly in vitro does not replicate the structures of α-synuclein filaments from multiple system atrophy. FEBS Open Bio 11, 999–1013 (2021).
Google Scholar
Tarutani, A. Cryo-EM structures of tau filaments from SH-SY5Y cells seeded with brain extracts from cases of Alzheimer’s disease and corticobasal degeneration. FEBS Open Bio 13, 1394–1404 (2023).
Google Scholar
Shahnawaz, M. et al. Discriminating α-synuclein strains in Parkinson’s disease and multiple system atrophy. Nature 578, 273–277 (2020).
Google Scholar
Siderowf, A. et al. Assessment of heterogeneity among participants in the Parkinson’s Progression Markers Initiative cohort using α-synuclein seed amplification: a cross-sectional study. Lancet Neurol. 22, 407–417 (2023).
Google Scholar
Cohen, S. I. A. et al. Proliferation of amyloid-β42 aggregates occurs through a secondary nucleation mechanism. Proc. Natl Acad. Sci. USA 110, 9758–9763 (2013).
Google Scholar
Benilova, I., Karran, E. & De Strooper, B. The toxic Aβ oligomer and Alzheimer’s disease: an emperor in need of clothes. Nat. Neurosci. 15, 349–357 (2012).
Google Scholar
Cremades, N. et al. Direct observation of the interconversion of normal and toxic forms of α-synuclein. Cell 149, 1048–1059 (2012).
Google Scholar
Weismiller, H. A. et al. Structural disorder in four-repeat Tau fibrils reveals a new mechanism for barriers to cross-seeding of Tau isoforms. J. Biol. Chem. 293, 17336–17348 (2018).
Google Scholar
Jackson, S. J. et al. Short fibrils constitute the major species of seed-competent tau in the brains of mice transgenic for human P301S tau. J. Neurosci. 36, 762–772 (2016).
Google Scholar
Legname, G. et al. Continuum of prion protein structures enciphers a multitude of prion isolate-specified phenotypes. Proc. Natl Acad. Sci. USA 103, 19105–19110 (2006).
Google Scholar
Morozova, O. A., March, Z. M., Robinson, A. S. & Colby, D. W. Conformational features of tau fibrils from Alzheimer’s disease brain are faithfully propagated by unmodified recombinant protein. Biochemistry 52, 6960–6967 (2013).
Google Scholar
Falcon, B. et al. Conformation determines the seeding potencies of native and recombinant tau aggregates. J. Biol. Chem. 290, 1049–1065 (2015).
Google Scholar
Saito, T. et al. Single App knock-in mouse models of Alzheimer’s disease. Nat. Neurosci. 17, 661–663 (2014).
Google Scholar
Leistner, C. et al. The in-tissue molecular architecture of β-amyloid in the mammalian brain. Nat. Commun. 14, 2833 (2022).
Google Scholar
Zielinski, M. et al. Cryo-EM structures of amyloid-β fibrils from Alzheimer’s disease mouse models. Preprint at bioRxiv (2023).
Hallinan, G. I. et al. Cryo-EM structures of prion protein filaments from Gerstmann–Sträussler–Scheinker disease. Acta Neuropathol. 144, 509–520 (2022). This study reports first structures of prion protein filaments from human brains.
Google Scholar
Murray, K. A. et al. De novo designed protein inhibitors of amyloid aggregation and seeding. Proc. Natl Acad. Sci. USA 119, e2206240119 (2022).
Google Scholar
Sahtoe, D. D. et al. Design of amyloidogenic peptide traps. Preprint at bioRxiv (2023).
Seidler, P. M. et al. Structure-based discovery of small molecules that disaggregate Alzheimer’s disease tissue derived tau fibrils in vitro. Nat. Commun. 13, 5451 (2022).
Google Scholar
Englund, H. et al. Sensitive ELISA detection of amyloid-β protofibrils in biological samples. J. Neurochem. 103, 334–345 (2007).
Google Scholar
